Pacific Health Care Organization, Inc. (PFHO)
OTCMKTS · Delayed Price · Currency is USD
0.8301
-0.0299 (-3.48%)
Jul 20, 2026, 12:18 PM EST
PFHO Market Cap
PFHO has a market cap or net worth of $10.63 million as of July 21, 2026. Its market cap has decreased by -6.73% in one year.
Market Cap
10.63M
Enterprise Value
-1.91M
Revenue
6.39M
Ranking
n/a
PE Ratio
8.25
Stock Price
$0.83
ChartMarket Cap Chart
Since April 20, 2004, PFHO's market cap has increased from 2.47M to 10.63M, an increase of 330.97%. That is a compound annual growth rate of 6.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 10.63M | -36.15% |
| Dec 31, 2025 | 16.64M | 80.68% |
| Dec 31, 2024 | 9.21M | 1.34% |
| Dec 29, 2023 | 9.09M | -6.58% |
| Dec 27, 2022 | 9.73M | -20.01% |
| Dec 31, 2021 | 12.16M | -4.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Veradigm | 517.71M |
| Silence Therapeutics | 495.96M |
| Elite Pharmaceuticals | 418.18M |
| VitaNova Life Sciences | 11.51M |
| Pharma-Bio Serv | 11.45M |
| Adia Med | 10.86M |
| Adaptimmune Therapeutics | 10.47M |